DISSOLUTION, STABILITY, AND MORPHOLOGICAL PROPERTIES OF CONVENTIONAL AND MULTIPHASE POLY(DL-LACTIC-CO-GLYCOLIC ACID) MICROSPHERES CONTAINING WATER-SOLUBLE COMPOUNDS

被引:39
作者
IWATA, M [1 ]
MCGINITY, JW [1 ]
机构
[1] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
关键词
POLY(LACTIC-CO-GLYCOLIC ACID); MULTIPHASE MICROSPHERES; WATER-SOLUBLE COMPOUNDS; IN-VITRO DISSOLUTION; MORPHOLOGY; BIODEGRADABLE DRUG DELIVERY SYSTEMS;
D O I
10.1023/A:1018984722208
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Multiphase microspheres Of poly(DL-lactic-co-glycolic acid) (PLGA) containing water-soluble compounds were prepared by a multiple-emulsion solvent evaporation technique. These compounds were dissolved in the aqueous phase of a W/O emulsion with soybean oil as the oil phase. This emulsion was dispersed throughout the matrix of the microsphere. The morphological properties of the multiphase microspheres during in vitro dissolution studies were compared to those of conventional microspheres prepared from the same polymer. Drug release from the multiphase microspheres was characterized by an initial uniform release for the first 20 days followed by a more rapid phase of drug release. Chlorpheniramine maleate (CPM) and brilliant blue (BB) were the soluble model compounds investigated. The release rates of these agents from the multiphase microspheres were independent of the drug content in the microspheres. The release profiles from the conventional microspheres showed a lag time of 10 and 16 days for the CPM and BB, respectively. The dissolution rate of the model soluble compounds from the conventional microspheres increased as the loading in the microspheres increased. No differences in the degradation rate of the PLGA from the multiphase and the conventional microspheres were seen during the dissolution studies.
引用
收藏
页码:1219 / 1227
页数:9
相关论文
共 18 条
[1]   POLYLACTIC ACID MICROSPHERES CONTAINING QUINIDINE BASE AND QUINIDINE SULFATE PREPARED BY THE SOLVENT EVAPORATION TECHNIQUE .1. METHODS AND MORPHOLOGY [J].
BODMEIER, R ;
MCGINITY, JW .
JOURNAL OF MICROENCAPSULATION, 1987, 4 (04) :279-288
[2]   THE PREPARATION AND EVALUATION OF DRUG-CONTAINING POLY(DL-LACTIDE) MICROSPHERES FORMED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :465-471
[3]   DISSOLUTION CHARACTERISTICS OF POLYCAPROLACTONE-POLYLACTIDE MICROSPHERES OF CHLORPROMAZINE [J].
CHANG, RK ;
PRICE, JC ;
WHITWORTH, CW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (14) :2355-2380
[4]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[5]  
IWATA M, 1992, J MICROENCAPSUL, V9, P201
[6]   MICROENCAPSULATION USING POLY (L-LACTIC ACID) .2. PREPARATIVE VARIABLES AFFECTING MICROCAPSULE PROPERTIES [J].
JALIL, R ;
NIXON, JR .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (01) :25-39
[7]   MICROENCAPSULATION USING POLY(L-LACTIC ACID) .1. MICROCAPSULE PROPERTIES AFFECTED BY THE PREPARATIVE TECHNIQUE [J].
JALIL, R ;
NIXON, JR .
JOURNAL OF MICROENCAPSULATION, 1989, 6 (04) :473-484
[8]   BIODEGRADABLE POLY(LACTIC ACID) AND POLY (LACTIDE-CO-GLYCOLIDE) POLYMERS IN SUSTAINED DRUG DELIVERY [J].
JALIL, RU .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (16) :2353-2367
[9]   STABILITY OF ATRIOPEPTIN-III IN POLY(D,L-LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].
JOHNSON, RE ;
LANASKI, LA ;
GUPTA, V ;
GRIFFIN, MJ ;
GAUD, HT ;
NEEDHAM, TE ;
ZIA, H .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (01) :61-67
[10]  
MCGINITY JW, 1992, FORMULATION WATER SO